Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $22.25 million. The enterprise value is $20.32 million.
| Market Cap | 22.25M |
| Enterprise Value | 20.32M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.54 million shares outstanding. The number of shares has increased by 1.98% in one year.
| Shares Outstanding | 10.54M |
| Shares Change (YoY) | +1.98% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 12.70% |
| Owned by Institutions (%) | 40.92% |
| Float | 5.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| Forward PS | 1.75 |
| PB Ratio | 2.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.21.
| Current Ratio | 4.22 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -718.00 |
Financial Efficiency
Return on equity (ROE) is -17.00% and return on invested capital (ROIC) is -15.04%.
| Return on Equity (ROE) | -17.00% |
| Return on Assets (ROA) | -12.90% |
| Return on Capital (ROIC) | -15.04% |
| Revenue Per Employee | $453,645 |
| Profits Per Employee | -$46,387 |
| Employee Count | 31 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 2.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.71% in the last 52 weeks. The beta is 1.19, so Nephros's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +50.71% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 2.46 |
| Relative Strength Index (RSI) | 47.71 |
| Average Volume (20 Days) | 10,674 |
Short Selling Information
The latest short interest is 3,824, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 3,824 |
| Short Previous Month | 2,505 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
In the last 12 months, Nephros had revenue of $14.06 million and -$1.44 million in losses. Loss per share was -$0.14.
| Revenue | 14.06M |
| Gross Profit | 8.48M |
| Operating Income | -1.49M |
| Pretax Income | -1.44M |
| Net Income | -1.44M |
| EBITDA | -1.24M |
| EBIT | -1.44M |
| Loss Per Share | -$0.14 |
Balance Sheet
The company has $3.63 million in cash and $1.71 million in debt, giving a net cash position of $1.92 million or $0.18 per share.
| Cash & Cash Equivalents | 3.63M |
| Total Debt | 1.71M |
| Net Cash | 1.92M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 8.18M |
| Book Value Per Share | 0.78 |
| Working Capital | 6.20M |
Cash Flow
In the last 12 months, operating cash flow was -$121,000 and capital expenditures -$75,000, giving a free cash flow of -$196,000.
| Operating Cash Flow | -121,000 |
| Capital Expenditures | -75,000 |
| Free Cash Flow | -196,000 |
| FCF Per Share | -$0.02 |
Margins
Gross margin is 60.31%, with operating and profit margins of -10.57% and -10.23%.
| Gross Margin | 60.31% |
| Operating Margin | -10.57% |
| Pretax Margin | -10.23% |
| Profit Margin | -10.23% |
| EBITDA Margin | -8.82% |
| EBIT Margin | -10.21% |
| FCF Margin | -1.39% |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.98% |
| Shareholder Yield | -1.98% |
| Earnings Yield | -6.46% |
| FCF Yield | -0.88% |
Analyst Forecast
The average price target for Nephros is $5.00, which is 136.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 136.97% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jul 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
Nephros has an Altman Z-Score of -12.14 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.14 |
| Piotroski F-Score | 3 |